{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:06:04Z","timestamp":1788404764605,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,12]]},"DOI":"10.7759\/cureus.27926","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T14:28:11Z","timestamp":1660314491000},"source":"Crossref","is-referenced-by-count":6,"title":["The Use of Cannabis and Its Effects on Postpartum Depression"],"prefix":"10.7759","author":[{"given":"Oghenetega E","family":"Ayisire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okelue E","family":"Okobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngozi J","family":"Adaralegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeyemi A","family":"Adeosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyaanshi","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkemputaife P","family":"Onyechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogochukwu","family":"Agazie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameed O","family":"Shittu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Akinsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwudike G","family":"Nnaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwasayo J","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka J","family":"Umeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imolikhe C","family":"Imobighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale M","family":"Adedoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madinah","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR\u2122). (2013). Accessed. March 4, 2022: https:\/\/www.appi.org\/dsm."},{"key":"ref2","unstructured":"BMJ best practices. postpartum depression. (2022). Accessed: July 4, 2022: https:\/\/bestpractice.bmj.com\/topics\/en-us\/512."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2217\/whe.12.55","article-title":"Biological aspects of postpartum depression","volume":"8","author":"Skalkidou A","year":"2012","unstructured":"Skalkidou A, Hellgren C, Comasco E, Sylv\u00e9n S, Sundstr\u00f6m Poromaa I. Biological aspects of postpartum depression. Womens Health (Lond). 2012, 8:659-72. 10.2217\/whe.12.55","journal-title":"Womens Health (Lond)"},{"key":"ref4","unstructured":"ACOG clinical. screening for perinatal depression. (2015). Accessed: April 18, 2022: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2018\/11\/screening-for-perinatal-depression."},{"key":"ref5","article-title":"Postpartum major depression","volume":"82","author":"Hirst KP","year":"2010","unstructured":"Hirst KP, Moutier CY. Postpartum major depression. AAFP. 2010, 82:926-33.","journal-title":"AAFP"},{"key":"ref6","unstructured":"CDC. depression during and after pregnancy. (2022). Accessed: May 1, 2022: https:\/\/www.cdc.gov\/reproductivehealth\/features\/maternal-depression\/index.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jmwh.12104","article-title":"Management of postpartum depression","volume":"58","author":"Guille C","year":"2013","unstructured":"Guille C, Newman R, Fryml LD, Lifton CK, Epperson CN. Management of postpartum depression. J Midwifery Womens Health. 2013, 58:643-53. 10.1111\/jmwh.12104","journal-title":"J Midwifery Womens Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1692685","article-title":"Self-reported alcohol, tobacco, and marijuana use in pregnant women with depressive symptomatology","volume":"37","author":"Hyer J","year":"2020","unstructured":"Hyer J, Ulrickson C, Yerelian E, Metz TD, Allshouse AA, Hoffman MC. Self-reported alcohol, tobacco, and marijuana use in pregnant women with depressive symptomatology. Am J Perinatol. 2020, 37:1223-7. 10.1055\/s-0039-1692685","journal-title":"Am J Perinatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2018.06.004","article-title":"Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: a systematic review","volume":"66","author":"Nillni YI","year":"2018","unstructured":"Nillni YI, Mehralizade A, Mayer L, Milanovic S. Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: a systematic review. Clin Psychol Rev. 2018, 66:136-48. 10.1016\/j.cpr.2018.06.004","journal-title":"Clin Psychol Rev"},{"key":"ref10","unstructured":"American Psychiatric Association. what is peripartum depression (formerly postpartum)?. (2020). Accessed: April 7, 2022: https:\/\/www.psychiatry.org\/patients-families\/postpartum-depression\/what-is-postpartum-depression."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-021-00934-0","article-title":"Does cannabidiol have a benefit as a supportive care drug in cancer?","volume":"23","author":"Lord S","year":"2022","unstructured":"Lord S, Hardy J, Good P. Does cannabidiol have a benefit as a supportive care drug in cancer?. Curr Treat Options Oncol. 2022, 23:514-25. 10.1007\/s11864-021-00934-0","journal-title":"Curr Treat Options Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2015.12.008","article-title":"Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers","volume":"54","author":"Emery RL","year":"2016","unstructured":"Emery RL, Gregory MP, Grace JL, Levine MD. Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers. Addict Behav. 2016, 54:52-8. 10.1016\/j.addbeh.2015.12.008","journal-title":"Addict Behav"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050141","article-title":"Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys","volume":"5","author":"Degenhardt L","year":"2008","unstructured":"Degenhardt L, Chiu WT, Sampson N, et al.. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008, 5:e141. 10.1371\/journal.pmed.0050141","journal-title":"PLoS Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.06.002","article-title":"Cannabis and depression: an integrative data analysis of four Australasian cohorts","volume":"126","author":"Horwood LJ","year":"2012","unstructured":"Horwood LJ, Fergusson DM, Coffey C, et al.. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend. 2012, 126:369-78. 10.1016\/j.drugalcdep.2012.06.002","journal-title":"Drug Alcohol Depend"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-57369-0_5","article-title":"Cannabis and depression","volume":"1264","author":"Feingold D","year":"2021","unstructured":"Feingold D, Weinstein A. Cannabis and depression. Adv Exp Med Biol. 2021, 1264:67-80. 10.1007\/978-3-030-57369-0_5","journal-title":"Adv Exp Med Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-136","article-title":"A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies","volume":"14","author":"Kedzior KK","year":"2014","unstructured":"Kedzior KK, Laeber LT. A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies. BMC Psychiatry. 2014, 14:136. 10.1186\/1471-244X-14-136","journal-title":"BMC Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey B","year":"2012","unstructured":"Wilsey B, Marcotte TD, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2012, 14:136-48. 10.1016\/j.jpain.2012.10.009","journal-title":"J Pain"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.03.030","article-title":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","volume":"177","author":"Childs E","year":"2017","unstructured":"Childs E, Lutz JA, de Wit H. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend. 2017, 177:136-44. 10.1016\/j.drugalcdep.2017.03.030","journal-title":"Drug Alcohol Depend"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1685298","article-title":"Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study","volume":"132","author":"Capano A","year":"2020","unstructured":"Capano A, Weaver R, Burkman E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2020, 132:56-61. 10.1080\/00325481.2019.1685298","journal-title":"Postgrad Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2000.0787","article-title":"The neurobiology and evolution of cannabinoid signalling","volume":"356","author":"Elphick MR","year":"2001","unstructured":"Elphick MR, Egertov\u00e1 M. The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci. 2001, 356:381-408. 10.1098\/rstb.2000.0787","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/19.200","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon S","year":"2020","unstructured":"Chayasirisobhon S. Mechanisms of action and pharmacokinetics of cannabis. Perm J. 2020, 25:19.200. 10.7812\/TPP\/19.200","journal-title":"Perm J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaa005","article-title":"The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders","volume":"26","author":"Maia J","year":"2020","unstructured":"Maia J, Fonseca B, Teixeira N, Correia-da-Silva G. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders. Hum Reprod Update. 2020, 26:586-602. 10.1093\/humupd\/dmaa005","journal-title":"Hum Reprod Update"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"Iversen L","year":"2003","unstructured":"Iversen L. Cannabis and the brain. Brain. 2003, 126:1252-70. 10.1093\/brain\/awg143","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.729800","article-title":"Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial","volume":"12","author":"Martin EL","year":"2021","unstructured":"Martin EL, Strickland JC, Schlienz NJ, Munson J, Jackson H, Bonn-Miller MO, Vandrey R. Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial. Front Psychiatry. 2021, 12:729800. 10.3389\/fpsyt.2021.729800","journal-title":"Front Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.12.1157","article-title":"Alteration in the hypothalamic-pituitary-ovarian axis in depressed women","volume":"57","author":"Young EA","year":"2000","unstructured":"Young EA, Midgley AR, Carlson NE, Brown MB. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry. 2000, 57:1157-62. 10.1001\/archpsyc.57.12.1157","journal-title":"Arch Gen Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2002.4.1\/bbondy","article-title":"Pathophysiology of depression and mechanisms of treatment","volume":"4","author":"Brigitta B","year":"2002","unstructured":"Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci. 2002, 4:7-20. 10.31887\/DCNS.2002.4.1\/bbondy","journal-title":"Dialogues Clin Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.01.025","article-title":"The neurobiology of depression: an integrated view","volume":"27","author":"Dean J","year":"2017","unstructured":"Dean J, Keshavan M. The neurobiology of depression: an integrated view. Asian J Psychiatr. 2017, 27:101-11. 10.1016\/j.ajp.2017.01.025","journal-title":"Asian J Psychiatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-1591(02)00009-0","article-title":"Cytokines, stress, and depressive illness","volume":"15","author":"Anisman H","year":"2002","unstructured":"Anisman H, Merali Z. Cytokines, stress, and depressive illness. Elsevier. 2002, 15:513-24. 10.1016\/S0889-1591(02)00009-0","journal-title":"Elsevier"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.0725","article-title":"The psychoneuroimmunology of postpartum depression","volume":"17","author":"Corwin EJ","year":"2008","unstructured":"Corwin EJ, Pajer K. The psychoneuroimmunology of postpartum depression. J Womens Health (Larchmt). 2008, 17:1529-34. 10.1089\/jwh.2007.0725","journal-title":"J Womens Health (Larchmt)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-12-36","article-title":"Breastfeeding cessation and symptoms of anxiety and depression: a longitudinal cohort study","volume":"12","author":"Ystrom E","year":"2012","unstructured":"Ystrom E. Breastfeeding cessation and symptoms of anxiety and depression: a longitudinal cohort study. BMC Pregnancy Childbirth. 2012, 12:36. 10.1186\/1471-2393-12-36","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(92)90028-Z","article-title":"Disturbances in dexamethasone suppression test and lower availability of \u0141-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy","volume":"36","author":"Maes M","year":"1992","unstructured":"Maes M, Claes M, Schotte C. Disturbances in dexamethasone suppression test and lower availability of \u0141-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. Elsevier. 1992, 36:191-7. 10.1016\/0022-3999(92)90028-Z","journal-title":"Elsevier"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: therapeutic use in clinical practice","volume":"23","author":"Pagano C","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci. 2022, 23:3344. 10.3390\/ijms23063344","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, blood-brain barrier, and brain disposition","volume":"12","author":"Calapai F","year":"2020","unstructured":"Calapai F, Cardia L, Sorbara EE, Navarra M, Gangemi S, Calapai G, Mannucci C. Cannabinoids, blood-brain barrier, and brain disposition. Pharmaceutics. 2020, 12:265. 10.3390\/pharmaceutics12030265","journal-title":"Pharmaceutics"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051123210","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier EJ","year":"2006","unstructured":"Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. PNAS. 2006, 103:7895-900. 10.1073\/pnas.051123210","journal-title":"PNAS"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.12.002","article-title":"Women's perspectives about cannabis use during pregnancy and the postpartum period: an integrative review","volume":"119","author":"Bayrampour H","year":"2019","unstructured":"Bayrampour H, Zahradnik M, Lisonkova S, Janssen P. Women's perspectives about cannabis use during pregnancy and the postpartum period: an integrative review. Prev Med. 2019, 119:17-23. 10.1016\/j.ypmed.2018.12.002","journal-title":"Prev Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107881","article-title":"Cannabis use during pregnancy in the United States: the role of depression","volume":"210","author":"Goodwin RD","year":"2020","unstructured":"Goodwin RD, Zhu J, Heisler Z, Metz TD, Wyka K, Wu M, Das Eiden R. Cannabis use during pregnancy in the United States: the role of depression. Drug Alcohol Depend. 2020, 210:107881. 10.1016\/j.drugalcdep.2020.107881","journal-title":"Drug Alcohol Depend"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108860","article-title":"Association between preconception cannabis use and risk of postpartum depression: findings from an Australian longitudinal cohort","volume":"226","author":"Cao S","year":"2021","unstructured":"Cao S, Jones M, Tooth L, Mishra GD. Association between preconception cannabis use and risk of postpartum depression: findings from an Australian longitudinal cohort. Drug Alcohol Depend. 2021, 226:108860. 10.1016\/j.drugalcdep.2021.108860","journal-title":"Drug Alcohol Depend"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000625","article-title":"Daily cannabis use during pregnancy and postpartum in a state with legalized recreational cannabis","volume":"14","author":"Barbosa-Leiker C","year":"2020","unstructured":"Barbosa-Leiker C, Burduli E, Smith CL, Brooks O, Orr M, Gartstein M. Daily cannabis use during pregnancy and postpartum in a state with legalized recreational cannabis. J Addict Med. 2020, 14:467-74. 10.1097\/ADM.0000000000000625","journal-title":"J Addict Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041863","article-title":"Cannabidiol as a potential treatment for anxiety and mood disorders: molecular targets and epigenetic insights from preclinical research","volume":"22","author":"Melas PA","year":"2021","unstructured":"Melas PA, Scherma M, Fratta W, Cifani C, Fadda P. Cannabidiol as a potential treatment for anxiety and mood disorders: molecular targets and epigenetic insights from preclinical research. Int J Mol Sci. 2021, 22:1863. 10.3390\/ijms22041863","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.12.009","article-title":"Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009 to 2016*","volume":"196","author":"Young-Wolff KC","year":"2019","unstructured":"Young-Wolff KC, Sarovar V, Tucker LY, et al.. Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009 to 2016*. Drug Alcohol Depend. 2019, 196:66-70. 10.1016\/j.drugalcdep.2018.12.009","journal-title":"Drug Alcohol Depend"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey AA","year":"2012","unstructured":"Rey AA, Purrio M, Viveros MP, Lutz B. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology. 2012, 37:2624-34. 10.1038\/npp.2012.123","journal-title":"Neuropsychopharmacology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000566","article-title":"The role of cannabis in treating anxiety: an update","volume":"33","author":"Van Ameringen M","year":"2020","unstructured":"Van Ameringen M, Zhang J, Patterson B, Turna J. The role of cannabis in treating anxiety: an update. Curr Opin Psychiatry. 2020, 33:1-7. 10.1097\/YCO.0000000000000566","journal-title":"Curr Opin Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00730","article-title":"Cannabis and the anxiety of fragmentation\u2014a systems approach for finding an anxiolytic cannabis chemotype","volume":"12","author":"Kamal BS","year":"2018","unstructured":"Kamal BS, Kamal F, Lantela DE. Cannabis and the anxiety of fragmentation\u2014a systems approach for finding an anxiolytic cannabis chemotype. Front Neurosci. 2018, 12:730. 10.3389\/fnins.2018.00730","journal-title":"Front Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000285","article-title":"The use of cannabinoids for sleep: a critical review on clinical trials","volume":"27","author":"Kuhathasan N","year":"2019","unstructured":"Kuhathasan N, Dufort A, MacKillop J, Gottschalk R, Minuzzi L, Frey BN. The use of cannabinoids for sleep: a critical review on clinical trials. Exp Clin Psychopharmacol. 2019, 27:383-401. 10.1037\/pha0000285","journal-title":"Exp Clin Psychopharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2020.101262","article-title":"Women's cannabis use before, during, and after pregnancy in New Hampshire","volume":"20","author":"Skelton KR","year":"2020","unstructured":"Skelton KR, Hecht AA, Benjamin-Neelon SE. Women's cannabis use before, during, and after pregnancy in New Hampshire. Prev Med Rep. 2020, 20:101262. 10.1016\/j.pmedr.2020.101262","journal-title":"Prev Med Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000826180.54174.26","article-title":"Evaluating the frequency of postpartum depression in marijuana users with and without a history of depression [A226]","volume":"139","author":"Richards R","year":"2022","unstructured":"Richards R, Benedict J, Lynch C, et al.. Evaluating the frequency of postpartum depression in marijuana users with and without a history of depression [A226]. ACOG. 2022, 139: 65S-6S. 10.1097\/01.AOG.0000826180.54174.26","journal-title":"ACOG"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0756-3","article-title":"Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study","volume":"10","author":"Farokhnia M","year":"2020","unstructured":"Farokhnia M, McDiarmid GR, Newmeyer MN, Munjal V, Abulseoud OA, Huestis MA, Leggio L. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Transl Psychiatry. 2020, 10:71. 10.1038\/s41398-020-0756-3","journal-title":"Transl Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2021.1898348","article-title":"Association between continued cannabis use during pregnancy and symptoms of anxiety and depression","volume":"33","author":"Mark K","year":"2021","unstructured":"Mark K, Otieno L, Moore E, Zehra A, Mitchell M. Association between continued cannabis use during pregnancy and symptoms of anxiety and depression. Int Rev Psychiatry. 2021, 33:528-33. 10.1080\/09540261.2021.1898348","journal-title":"Int Rev Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.02.017","article-title":"Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study","volume":"187","author":"Ko JY","year":"2018","unstructured":"Ko JY, Tong VT, Bombard JM, Hayes DK, Davy J, Perham-Hester KA. Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study. Drug Alcohol Depend. 2018, 187:72-8. 10.1016\/j.drugalcdep.2018.02.017","journal-title":"Drug Alcohol Depend"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3233\/NPM-17125","article-title":"Is Breast Best? Examining the effects of alcohol and cannabis use during lactation","volume":"11","author":"Brown RA","year":"2018","unstructured":"Brown RA, Dakkak H, Seabrook JA. Is Breast Best? Examining the effects of alcohol and cannabis use during lactation. J Neonatal Perinatal Med. 2018, 11:345-56. 10.3233\/NPM-17125","journal-title":"J Neonatal Perinatal Med"},{"key":"ref51","article-title":"Marijuana and Maternal, Perinatal, and Neonatal Outcomes","author":"Shukla S","year":"2022","unstructured":"Shukla S, Doshi H. Marijuana and Maternal, Perinatal, and Neonatal Outcomes. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198209233071311","article-title":"Presence of delta9-tetrahydrocannabinol in human milk","volume":"307","author":"Perez-Reyes M","year":"1982","unstructured":"Perez-Reyes M, Wall ME. Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med. 1982, 307:819-20. 10.1056\/NEJM198209233071311","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002878","article-title":"Marijuana use in pregnancy and while breastfeeding","volume":"132","author":"Metz TD","year":"2018","unstructured":"Metz TD, Borgelt LM. Marijuana use in pregnancy and while breastfeeding. Obstet Gynecol. 2018, 132:1198-210. 10.1097\/AOG.0000000000002878","journal-title":"Obstet Gynecol"},{"key":"ref54","article-title":"Birth outcomes of neonates exposed to marijuana in utero","volume":"5","author":"Marchand G","year":"2022","unstructured":"Marchand G, Masoud AT, Govindan M, et al.. Birth outcomes of neonates exposed to marijuana in utero. JAMA. 2022, 5:e2145653.","journal-title":"JAMA"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.5494","article-title":"Association of cannabis use with self-harm and mortality risk among youths with mood disorders","volume":"175","author":"Fontanella CA","year":"2021","unstructured":"Fontanella CA, Steelesmith DL, Brock G, Bridge JA, Campo JV, Fristad MA. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. 2021, 175:377-84. 10.1001\/jamapediatrics.2020.5494","journal-title":"JAMA Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107891-the-use-of-cannabis-and-its-effects-on-postpartum-depression","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:44Z","timestamp":1707508064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107891-the-use-of-cannabis-and-its-effects-on-postpartum-depression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.27926","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}